drugset / Trial / NCT02307383
Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers
NaSingle-groupOpen-labelTreatment
Summary
The combination of Lactitol and Probiotics (Lactobacillus acidophilus and Lactobacillus Biphidus) administered orally is an effective strategy of intestinal decolonization of Enterobacter produced OXA-48-type carbapenemase. The purpose of this study is to determine the effectiveness of Lactitol and Probiotics for the intestinal decolonization of people who carried Klebsiella pneumoniae produced OXA-48-type Carbapenemase.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bifidobacterium bifidum | Unknown | 1e+09 cells | Oral |
| Subject | Lactitol | Small molecule | 10 g | Oral |
| Subject | Lactobacillus acidophilus | Other / unclassified | 1e+09 cells | Oral |
Indications
No indication recorded.